Precision medicine approaches to lung adenocarcinoma with concomitant MET and HER2 amplification

BACKGROUND: Patient-derived xenograft (PDX) models are important tools in precision medicine and for the development of targeted therapies to treat cancer patients. This study aimed to evaluate our precision medicine strategy that integrates genomic profiling and preclinical drug-screening platforms...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:BMC Cancer
Egile Nagusiak: Oh, Doo-Yi, Jung, Kyungsoo, Song, Ji-Young, Kim, Seokhwi, Shin, Sang, Kwon, Yong-Jun, Oh, Ensel, Park, Woong-Yang, Song, Sang Yong, Choi, Yoon-La
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: BioMed Central 2017
Gaiak:
Research Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC5557466/
https://ncbi.nlm.nih.gov/pubmed/28806950
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-017-3525-9
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak